Breast Cancer

Women with Early Stage Cancer Offered Faster Radiation Treatment Option

Published in Cancer Weekly, July 13th, 1998

The U.S. National Institutes of Health (NIH) has sponsored a study of radiation treatment which tracks women with early stage breast cancer and their treatment with High Dose Rate (HDR) brachytherapy, an outpatient radiation therapy.

In the past, breast conservation treatment (BCT) has meant a lumpectomy with six weeks of radiation. Seven nationally recognized studies have demonstrated that BCT outcomes are equivalent to a mastectomy in terms of survival rates. While BCT has strong emotional appeal for women who want to save their breast, the six week cycle of radiation has been a deterrent in the past.

An innovative radiation treatment known as...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (1998-07-13)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry